Poland· PL-100223406

Dultavax

A diphtherie-poliomyelitis-tetanus product containing vaccinum diphtheriae, tetani et poliomyelitidis inactivatum, antigeniis minutum, adsorbatum szczepionka przeciw błonicy, tężcowi i poliomyelitis (inaktywowana), adsorbowana, o zmniejszonej zawartości antygenów, registered in Poland by Sanofi Pasteur. The same ATC class is registered in 5 of our 19 countries.

ATC J07CA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDultavaxATCJ07CA01REGISTER NO.PL-100223406PACKS LISTED7CHECKEDSeptember 27, 2026

Where it is registered

Diphtherie-poliomyelitis-tetanus is registered in 5 of 19 countries.

Countries holding a registration under ATC J07CA01 (diphtherie-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Diphtherie-poliomyelitis-tetanus · ATC J07CA01

5 / 19 countries

  • Belgiumprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Vaccinum diphtheriae, tetani et poliomyelitidis inactivatum, antigeniis minutum, adsorbatum Szczepionka przeciw błonicy, tężcowi i poliomyelitis (inaktywowana), adsorbowana, o zmniejszonej zawartości antygenów
Manufacturer
Sanofi Pasteur
Country
Poland (PL)
ATC code
J07CA01
ATC class
Diphtherie-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909991065324
  • gtin
    05909991065331
  • gtin
    05909990649044
  • gtin
    05909990649051
  • gtin
    05909990649068
  • gtin
    05909990649075
  • gtin
    05909991065317

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/65a666fc-d0dc-4e26-83f2-07b62095509d
GET /v1/drugs/65a666fc-d0dc-4e26-83f2-07b62095509d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina do wstrzykiwań",
  "source": "urpl",
  "strength": "nie mniej niż 2 j.m. + nie mniej niż 20 j.m. + 40 jednostek antygenu D + 8 jednostek antygenu D + 32 jednostki antygenu D/0,5 ml, 1 dawka (0,5 ml)",
  "packaging": "05909991065317 ¦ Rp ¦ 23307\n1 amp.-strzyk. 1 ml z igłą\n05909991065324 ¦ Rp ¦ 23308\n10 amp.-strzyk. 0,5 ml\n05909991065331 ¦ Rp ¦ Skasowane ¦ 23314\n20 amp.-strzyk. 0,5 ml\n05909990649044 ¦ Rp ¦ 43814\n10 amp.-strzyk. 0,5 ml ¦ 20 igieł \n05909990649051 ¦ Rp ¦ 43815\n1 amp.-strzyk. 0,5 ml ¦ 1 igła \n05909990649068 ¦ Rp ¦ 43816\n1 amp.-strzyk. 0,5 ml ¦ 2 igły \n05909990649075 ¦ Rp ¦ 43817\n10 amp.-strzyk. 0,5 ml ¦ 10 igieł",
  "substance": "Wirus poliomyelitis typ 2, szczep MEF-1 (inaktywowany) ad 1 ml + Toksoid tężcowy 0,01 g/10 ml + Toksoid błoniczy 0,01 g/10 ml + Wirus poliomyelitis typ 3, szczep Saukett (inaktywowany) 32 jednostki antygenu D + Wirus poliomyelitis typ 1, szczep Mahoney (inaktywowany) 1,245 g/10 ml",
  "common_name": "Vaccinum diphtheriae, tetani et poliomyelitidis inactivatum, antigeniis minutum, adsorbatum Szczepionka przeciw błonicy, tężcowi i poliomyelitis (inaktywowana), adsorbowana, o zmniejszonej zawartości antygenów",
  "pl_product_id": "100223406",
  "pozwolenie_nr": "10653",
  "auth_procedure": "NAR",
  "authorisation_validity": "2024-10-04"
}

See everything about diphtherie-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.